A carregar...
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
Background: Inhibitors of proprotein convertase subtilisin kexin 9 are indicated in Canada for treatment of patients with familial hypercholesterolemia (FH). Classically, FH is considered to be a monogenic condition caused by rare pathogenic mutations; however, some patients have hypercholesterolemi...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019-05-01
|
| Colecção: | CJC Open |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2589790X19300137 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|